An interventional study of Taurine group and exercise and placebo group and exercise and Physical training with Deep Water Running in Obesity, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to female participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2020-11-30.
Sponsored by University of Sao Paulo · Not applicable, Interventional, and Other
Irisin is a myocin secreted by skeletal muscle in stimulus to physical exercise and has been described as a possible therapeutic tool in the fight against obesity by triggering a cascade of signaling that triggers the expression of genes responsible for the increase in energy expenditure and browning of adipose tissue white cells by activating thermogenesis promoter mitochondrial proteins. Although the science is engaged in the search for evidences about the actions of the irisin, the physical exercise involved and the improvement in the levels of obesity, many mechanisms are still unknown. Since taurine by means of irisin-like pathways also increases energy expenditure, it is believed that taurine supplementation associated with high intensity aerobic physical exercise can optimize the effects of irisin, increasing energy expenditure and improving body composition in obesity.
Introduction: Irisin is a myocin secreted by skeletal muscle when stimulated by physical exercise that promotes increased thermogenesis (browning effect). Similarly, taurine is also associated with modulations of energy metabolism with promising actions in the control of metabolic disorders. Thus, it is believed that chronic taurine supplementation associated with physical training can optimize irisin concentrations after exercise.
Objective: Evaluate the effects of taurine supplementation associated with interval aerobic training on plasma irisin concentrations, energy expenditure, body composition and physical fitness in obese women. Methods: Twenty-two women aged 25 to 45 years, sedentary, with grade I obesity (BMI ≥30-35 kg / m²) and without comorbidities will be recruited for the study. The subjects will be submited to a high intensity interval aerobic training for 8 weeks, being 3 times by week, for 50 minutes, associated to the supplementation with 3g of taurine or placebo.
Methods: Assessment of dietary intake, Resting Energy Expenditure (GER) by indirect calorimetry, body composition by deuterium oxide, anthropometric measurements, HPLC plasma analysis of taurine, multiplex irisin and physical fitness variables will be performed pre and post intervention. The results will be expressed as mean and standard deviation and the ANOVA test two way repeated measures mixed model will be applied, with post hoc Sidak, to verify differences and statistical interactions (p \<0.05).
6,296 studies on the registry are indexed under Obesity; 1,695 are open to participants now.
This study's enrollment of 31 is below the median of 78 across 4,878 interventional studies indexed under Obesity.
Browse Obesity studies →University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Intervention with taurine supplementation and physical training.
Dietary Supplement: Taurine group and exercise and placebo group and exercise · Other: Physical training with Deep Water Running
Intervention with placebo supplementation and physical training.
Dietary Supplement: Taurine group and exercise and placebo group and exercise · Other: Physical training with Deep Water Running
Both groups supplemented with taurine and / or placebo will perform physical training.
There will be a physical training for eight weeks.
Changes body weight
The body weight was measured by digital balance before and after the intervention
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Changes body composition
The body composition was evaluated through deuterium oxide
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Changes indirect calorimetry
With a gas analyzer (indirect calorimeter), we evaluated the metabolic rate and rest (REE) and oxidation of substrates (lipids and carbohydrates)
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Changes in total cholesterol and lipid fractions
Collected in EDTA tubes, were centrifuged.
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Changes in plasma taurine concentration
Collected in EDTA tubes, were centrifuged and the plasma taurine concentration was evaluated using HPLC (high performance liquid chromatography).
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Changes in plasma irisin concentration
Collected in EDTA tubes, were centrifuged and the plasma irisin concentration was evaluated using Multiplex - Kit Human Myokine Magnetic Bead Panel.
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Changes Food intake
Food registry of 3 days. The quantification of the daily intake of nutrients will still be made using sofware.
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Changes in determination of lactate
Blood samples were collected by manual puncture of the earlobe in previously calibrated and heparinized capillary tubes, stored in eppendorf with sodium fluoride. Analyzed by electrochemical lactate analyser.
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Changes Physical Performance
Maximum effort test, according to Wilder, Brennan e Schotte (1993).
Time frame: Two times: (1) First day and (2) 10 weeks after assessments, adaptation and intervention
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Sao Paulo